screening that have contributed to these discoveries and some of the challenges that remain.

9:15

Human papillomavirus infection as the cause of cervical cancer

Eduardo Franco, McGill University

9:45

Infectious agents and cardiovascular disease

Michael Dunne, Pfizer, Inc.

10:15

Infectious agents and demyelinating diseases

Richard Johnson, Johns Hopkins University School of Medicine

10:45

The role of infectious agents in schizophrenia, bipolar disorder, and other serious neuropsychiatric diseases

Robert Yolken and E. Fuller Torrey, Johns Hopkins University School of Medicine and Stanley Foundation

11:15

BREAK

11:30

Common infections and uncommon disease: Elusive associations of enteroviruses and type I diabetes mellitus

Mark Pallansch, Centers for Disease Control and Prevention

12:00 p.m.

Chronic hepatitis B virus infections

William Mason, Fox Chase Cancer Center

12:30

Retrovirus-induced lung cancer in sheep:

Perspectives on the human disease

Hung Fan, University of California, Irvine

1:00

LUNCH

Session II Challenges in Framing the Research

Identification and confirmation of the infectious causation of chronic diseases are complicated by several factors, which include detection of microbes at the time of diagnosis of the chronic condition, the lack of adequate methods to identify novel or rare microorganisms, and the influence of environmental and genetic factors on the etiology of the chronic diseases. This session will examine these challenges and identify existing and potential methods and technologies for overcoming these obstacles.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement